108,000,000 Shares of HighTide Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 21-MAY-2024. These Shares will be under lockup for 152 days starting from 21-DEC-2023 to 21-MAY-2024.

Details:
The shares held by the Pre-IPO Investors and the Founder BVI, being 53,313,484 shares ( including the Shares held by Greaty Investment, ZT Global Energy, Orient Champion and all other Pre-IPO Investors, but excluding the 18,000,000 (108,000,000 as adjusted after the Capitalization Issue) ordinary Shares held by Hepalink Biotechnology II Limited, which will be subject to lock-up for five months commencing from the Listing Date) will be subject to lock-up for a period of six months commencing from the Listing date.